Accordingly, the FAO inhibitor etomoxir, which inhibits the rate-limiting FAO enzyme carnitine palmitoyltransferase 1 (CPT1C), suppresses the growth of xenograft tumors derived from MYCN-amplified neuroblastoma (45). This evidence concerns the gene CPT1C and neuroblastoma.